Larimar Therapeutics Inc (LRMR)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: LRMR Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-05-31	2024-02-16	B Purchase	Hamilton Thomas Edward Non-Executive Director	57,208 +11.3% 8.74 USD 499,998	57,208 +11.3%	8.74	USD 499,998
2024-02-16	2024-02-16	B Purchase	Flynn James E Non-Executive Director Large shareholder	1,430,205 +51.5% 8.74 USD 12,499,992	1,430,205 +51.5%	8.74	USD 12,499,992
2024-02-16	2024-02-16	B Purchase	Flynn James E Non-Executive Director Large shareholder	1,430,206 +30.3% 8.74 USD 12,500,000	1,430,206 +30.3%	8.74	USD 12,500,000
2024-02-16	2024-02-16	B Purchase	Flynn James E Non-Executive Director Large shareholder	1,430,206 +30.3% 8.74 USD 12,500,000	1,430,206 +30.3%	8.74	USD 12,500,000
2024-02-15	2024-02-14	B Purchase	THOMAS FRANK E Non-Executive Director	2,000 +inf% 11.00 USD 22,000	2,000 +inf%	11.00	USD 22,000
2023-12-08	2023-12-07	B Purchase	Shankar Gopi Chief Development Officer Officer	5,000 +inf% 3.73 USD 18,662	5,000 +inf%	3.73	USD 18,662
2023-05-18	2023-05-17	B Purchase	BEN-MAIMON CAROLE President and CEO Executive Director	5,000 +1.9% 3.71 USD 18,525	5,000 +1.9%	3.71	USD 18,525
2023-05-18	2023-05-17	B Purchase	Truitt Joseph Non-Executive Director	2,750 +inf% 3.73 USD 10,258	2,750 +inf%	3.73	USD 10,258
2023-05-18	2023-05-17	B Purchase	Celano Michael Chief Financial Officer Officer	5,000 +4.6% 3.73 USD 18,632	5,000 +4.6%	3.73	USD 18,632
2022-09-20	2022-09-16	B Purchase	Flynn James E Non-Executive Director Large shareholder	2,777,777 +inf% 3.15 USD 8,749,998	2,777,777 +inf%	3.15	USD 8,749,998
2022-09-20	2022-09-16	B Purchase	Flynn James E Non-Executive Director Large shareholder	2,777,777 +142.9% 3.15 USD 8,749,998	2,777,777 +142.9%	3.15	USD 8,749,998
2022-09-20	2022-09-16	B Purchase	Flynn James E Non-Executive Director Large shareholder	2,777,777 +142.9% 3.15 USD 8,749,998	2,777,777 +142.9%	3.15	USD 8,749,998
2022-09-20	2022-09-16	B Purchase	Flynn James E Non-Executive Director Large shareholder	2,777,777 +142.9% 3.15 USD 8,749,998	2,777,777 +142.9%	3.15	USD 8,749,998
2022-09-20	2022-09-16	B Purchase	Hamilton Thomas Edward Non-Executive Director	317,460 +167.0% 3.15 USD 999,999	317,460 +167.0%	3.15	USD 999,999
2022-09-19	2022-09-16	B Purchase	BEN-MAIMON CAROLE President and CEO Executive Director	31,746 +126.6% 3.15 USD 100,000	31,746 +126.6%	3.15	USD 100,000
2022-09-19	2022-09-16	B Purchase	Celano Michael Chief Financial Officer Officer	31,746 +inf% 3.15 USD 100,000	31,746 +inf%	3.15	USD 100,000
2018-06-29	2018-06-28	PS Planned sale	Hughes Thomas E. See Remarks Executive Director	32,000 -20.4% 10.00 USD 320,000	32,000 -20.4%	10.00	USD 320,000
2018-03-09	2018-03-07	PS Planned sale	Hughes Thomas E. See Remarks Executive Director	5,000 -3.1% 10.00 USD 50,000	5,000 -3.1%	10.00	USD 50,000
2017-10-17	2017-10-13	B Purchase	Heller Frances K	10,000 +26.3% 3.90 USD 38,988	10,000 +26.3%	3.90	USD 38,988
2017-07-12	2017-07-11	B Purchase	KIM DENNIS D Chief Medical Officer Officer	10,000 +87.4% 3.39 USD 33,900	10,000 +87.4%	3.39	USD 33,900
2017-05-11	2017-05-11	PP Planned purchase	KIM DENNIS D Chief Medical Officer Officer	9,800 +596.5% 4.40 USD 43,120	9,800 +596.5%	4.40	USD 43,120
2017-05-11	2017-05-10	PP Planned purchase	KIM DENNIS D Chief Medical Officer Officer	200 +13.9% 4.40 USD 880	200 +13.9%	4.40	USD 880
2016-12-20	2016-12-19	B Purchase	Heller Frances K Non-Executive Director	10,000 +50.0% 3.23 USD 32,290	10,000 +50.0%	3.23	USD 32,290
2016-11-17	2016-11-15	B Purchase	Heller Frances K Non-Executive Director	10,000 +100.0% 3.54 USD 35,434	10,000 +100.0%	3.54	USD 35,434
2016-08-31	2016-08-29	B Purchase	Hughes Thomas E. President and CEO Executive Director	10,000 +18.5% 3.00 USD 29,987	10,000 +18.5%	3.00	USD 29,987
2016-07-26	2016-07-26	PP Planned purchase	Allen Patricia L Chief Financial Officer Officer	8,200 +70.7% 3.15 USD 25,830	8,200 +70.7%	3.15	USD 25,830
2016-07-26	2016-07-25	B Purchase	Allen Patricia L Chief Financial Officer Officer	7,800 +205.6% 3.08 USD 24,032	7,800 +205.6%	3.08	USD 24,032
2016-07-26	2016-07-22	PP Planned purchase	Hughes Thomas E. President and CEO Executive Director	5,000 +10.2% 3.02 USD 15,104	5,000 +10.2%	3.02	USD 15,104
2016-07-26	2016-07-22	B Purchase	Heller Frances K Non-Executive Director	10,000 +inf% 2.99 USD 29,900	10,000 +inf%	2.99	USD 29,900
2016-08-01	2016-07-20	S Sale	Flynn James E Large shareholder	901,430 -43.9% 3.31 USD 2,985,356	901,430 -43.9%	3.31	USD 2,985,356
2016-08-01	2016-07-20	S Sale	Flynn James E Large shareholder	246,439 -43.9% 3.31 USD 816,157	246,439 -43.9%	3.31	USD 816,157
2016-08-01	2016-07-20	S Sale	Flynn James E Large shareholder	193,630 -43.9% 3.31 USD 641,264	193,630 -43.9%	3.31	USD 641,264
2016-02-17	2016-02-12	B Purchase	Flynn James E Large shareholder	13,872 +0.7% 6.25 USD 86,653	13,872 +0.7%	6.25	USD 86,653
2016-02-17	2016-02-12	B Purchase	Flynn James E Large shareholder	28,377 +5.3% 6.25 USD 177,260	28,377 +5.3%	6.25	USD 177,260
2016-02-17	2016-02-12	B Purchase	Flynn James E Large shareholder	22,296 +5.3% 6.25 USD 139,274	22,296 +5.3%	6.25	USD 139,274
2016-02-11	2016-02-11	B Purchase	Flynn James E Large shareholder	504 +0.0% 6.19 USD 3,119	504 +0.0%	6.19	USD 3,119
2016-02-11	2016-02-11	B Purchase	Flynn James E Large shareholder	1,030 +0.2% 6.19 USD 6,374	1,030 +0.2%	6.19	USD 6,374
2016-02-11	2016-02-11	B Purchase	Flynn James E Large shareholder	810 +0.2% 6.19 USD 5,013	810 +0.2%	6.19	USD 5,013
2016-02-11	2016-02-10	B Purchase	Flynn James E Large shareholder	32,501 +1.6% 6.23 USD 202,556	32,501 +1.6%	6.23	USD 202,556
2016-02-11	2016-02-10	B Purchase	Flynn James E Large shareholder	66,486 +14.3% 6.23 USD 414,361	66,486 +14.3%	6.23	USD 414,361
2016-02-11	2016-02-10	B Purchase	Flynn James E Large shareholder	52,239 +14.3% 6.23 USD 325,569	52,239 +14.3%	6.23	USD 325,569
2016-02-11	2016-02-09	B Purchase	Flynn James E Large shareholder	24,484 +1.2% 5.73 USD 140,271	24,484 +1.2%	5.73	USD 140,271
2016-02-11	2016-02-09	B Purchase	Flynn James E Large shareholder	50,086 +12.1% 5.73 USD 286,948	50,086 +12.1%	5.73	USD 286,948
2016-02-11	2016-02-09	B Purchase	Flynn James E Large shareholder	39,353 +12.1% 5.73 USD 225,457	39,353 +12.1%	5.73	USD 225,457
2015-09-25	2015-09-24	S Sale	STARR KEVIN P Non-Executive Director	61,630 -22.7% 44.10 USD 2,717,883	61,630 -22.7%	44.10	USD 2,717,883
2015-09-25	2015-09-24	S Sale	STARR KEVIN P Non-Executive Director	74,949 -21.6% 43.73 USD 3,277,520	74,949 -21.6%	43.73	USD 3,277,520
2015-09-21	2015-09-18	PS Planned sale	Hughes Thomas E. Chief Executive Officer Executive Director	23,126 -96.6% 45.00 USD 1,040,670	23,126 -96.6%	45.00	USD 1,040,670
2015-09-21	2015-09-17	PS Planned sale	Hughes Thomas E. Chief Executive Officer Executive Director	22,500 -96.5% 40.00 USD 900,000	22,500 -96.5%	40.00	USD 900,000
2015-09-21	2015-09-17	PS Planned sale	Secor Alicia Chief Commercial Officer Officer	1,256 -100.0% 41.05 USD 51,559	1,256 -100.0%	41.05	USD 51,559
2015-09-21	2015-09-17	PS Planned sale	Secor Alicia Chief Commercial Officer Officer	25,000 -95.2% 41.05 USD 1,026,250	25,000 -95.2%	41.05	USD 1,026,250
2015-09-17	2015-09-17	S Sale	KIM DENNIS D Chief Medical Officer Officer	9,142 -100.0% 40.00 USD 365,680	9,142 -100.0%	40.00	USD 365,680
2015-09-17	2015-09-15	S Sale	KIM DENNIS D Chief Medical Officer Officer	30,265 -100.0% 40.00 USD 1,210,600	30,265 -100.0%	40.00	USD 1,210,600
2015-09-16	2015-09-14	S Sale	KIM DENNIS D Chief Medical Officer Officer	593 -100.0% 40.00 USD 23,720	593 -100.0%	40.00	USD 23,720
2014-06-23	2014-06-19	B Purchase	Secor Alicia Chief Commercial Officer Officer	4,000 +inf% 20.00 USD 80,000	4,000 +inf%	20.00	USD 80,000

Larimar Therapeutics Inc (LRMR)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by